11.80
0.29 (2.52%)
| Previous Close | 11.51 |
| Open | 11.56 |
| Volume | 570,300 |
| Avg. Volume (3M) | 425,704 |
| Market Cap | 487,737,728 |
| Price / Sales | 6.61 |
| Price / Book | 3.57 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2026 |
| Profit Margin | -27.64% |
| Operating Margin (TTM) | -72.40% |
| Diluted EPS (TTM) | -2.22 |
| Quarterly Revenue Growth (YOY) | 58.70% |
| Total Debt/Equity (MRQ) | 2.36% |
| Current Ratio (MRQ) | 7.62 |
| Operating Cash Flow (TTM) | -35.91 M |
| Levered Free Cash Flow (TTM) | -10.42 M |
| Return on Assets (TTM) | -16.03% |
| Return on Equity (TTM) | -48.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | 908 Devices Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | -1.17 |
Select this tab to load the latest available analysis.
|
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 8.42% |
| % Held by Institutions | 74.13% |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |